Advertisement
ISRG vs PODD
Which Stock Would AI Choose? Intuitive Surgical (ISRG) vs. Insulet Corporation (PODD) Stock Comparison
Key Takeaways
- Intuitive Surgical (ISRG) boasts a significantly larger market capitalization of approximately $165 billion compared to Insulet Corporation's (PODD) $14 billion, reflecting greater scale in robotic surgery.
- Both stocks have experienced pullbacks in recent weeks, with PODD showing steeper declines of around 10% over the past month amid competitive pressures.
- ISRG trades at a P/E ratio (price-to-earnings ratio) of about 59, similar to PODD's 58, indicating comparable valuations despite differing business focuses.
- Analyst sentiment remains mixed for both, with recent price target reductions ahead of ISRG's Q1 earnings and ongoing bullish ratings for PODD despite share weakness.
- ISRG demonstrates relatively stronger short-term momentum, up 2.25% over five days versus PODD's 0.56%.
- Regulatory scrutiny impacts both, but ISRG's procedure growth and low market penetration provide sustained catalysts.
Introduction
Intuitive Surgical (ISRG) and Insulet Corporation (PODD) represent key players in the medical device sector, focusing on innovative technologies for surgical procedures and diabetes management, respectively. This comparison is particularly relevant for growth-oriented investors and traders navigating healthcare stocks amid recent market volatility and regulatory developments. Both companies have faced share price pressure in recent weeks due to analyst adjustments and sector headwinds, yet they offer distinct exposure to high-growth areas like robotics and insulin delivery systems. Understanding their relative performance, valuations, and catalysts can aid in assessing positioning within a dynamic medtech landscape.
ISRG Overview and Recent Performance
Intuitive Surgical (ISRG) is a leader in robotic-assisted minimally invasive surgery, primarily through its da Vinci Surgical System and Ion Endoluminal System. The company benefits from expanding procedure volumes and low penetration in a vast total addressable market (TAM). In recent market activity, ISRG shares have pulled back modestly, trading around $465–$470 after a 52-week high near $604, influenced by pre-earnings caution and lowered price targets from firms like Mizuho and Truist amid FDA scrutiny on product safety. Sentiment reflects mixed views, with sustained growth prospects from rising procedures offsetting regulatory concerns, contributing to a one-month decline of about 1.8% while maintaining relative stability.
PODD Overview and Recent Performance
Insulet Corporation (PODD) specializes in tubeless insulin delivery systems via its Omnipod platform, targeting diabetes management with user-friendly automated solutions. The company has driven growth through product innovations and market expansion. Recent weeks have seen sharper share declines to around $200–$202 from a 52-week high of $355, pressured by competitive risks highlighted by Citi, CMS bidding dynamics, and adjusted price targets from RBC Capital and BTIG, despite a Q4 earnings beat earlier in the year. Bullish analyst ratings persist, bolstered by a new Chief Commercial Officer appointment, but one-month performance lags at approximately -10%, reflecting heightened sensitivity to sector competition.
Trending AI Robots
Tickeron's Trending AI Robots page curates the top 25 performers from over 351 AI trading bots that generate real-time signals across thousands of stocks, ETFs, and cryptocurrencies. These bots employ diverse strategies such as swing trading, trend following, dip buying, and multi-agent approaches with take-profit/stop-loss mechanisms, operating on timeframes from 5 minutes to 60 minutes. Standout stats include annualized returns ranging from 15% to over 167%, win rates of 54%–88%, profit factors up to 11.7, and profit-to-drawdown ratios as high as 22. Examples feature semiconductor-focused bots with +97% returns and 69% win rates on tickers like SOXL, alongside industrials swing traders at +34% annualized. Ideal for current conditions, these bots adapt to market shifts. Traders can explore the Trending AI Robots page for copy trading options tailored to various risk profiles.
Head-to-Head Comparison
ISRG and PODD both operate in healthcare equipment but diverge in focus: ISRG's broad surgical robotics contrasts with PODD's niche diabetes insulin delivery. Growth drivers for ISRG include procedure expansion and system upgrades, while PODD relies on Omnipod adoption amid reimbursement changes. Recent momentum favors ISRG with milder pullbacks, though PODD shows higher volatility (beta 1.08 vs. 1.28). Risk factors encompass regulatory hurdles for both—FDA for ISRG, CMS bidding for PODD—with ISRG offering superior scale and market sentiment stability despite similar P/E ratios. Sector exposure ties them to medtech cycles, where ISRG edges on diversification trade-offs.
Tickeron AI Verdict
Tickeron's AI currently leans toward ISRG based on trend consistency, relative momentum stability in recent weeks, and robust procedure growth catalysts amid low penetration. While PODD presents undervaluation potential, its sharper declines and competitive risks suggest higher near-term uncertainty. This positioning reflects probabilistic edges rather than guarantees, aligning with observable market dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISRG is a Hold and PODD is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ISRG’s FA Score shows that 0 FA rating(s) are green whilePODD’s FA Score has 0 green FA rating(s).
- ISRG’s FA Score: 0 green, 5 red.
- PODD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ISRG’s TA Score shows that 5 TA indicator(s) are bullish while PODD’s TA Score has 5 bullish TA indicator(s).
- ISRG’s TA Score: 5 bullish, 3 bearish.
- PODD’s TA Score: 5 bullish, 3 bearish.
Price Growth
ISRG (@Pharmaceuticals: Other) experienced а -1.48% price change this week, while PODD (@Medical/Nursing Services) price change was -2.30% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.06%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was -12.66%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +23.45%. For the same industry, the average monthly price growth was +12.35%, and the average quarterly price growth was -13.81%.
Reported Earning Dates
ISRG is expected to report earnings on Jul 16, 2026.
PODD is expected to report earnings on Aug 06, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+3.06% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+23.45% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ISRG | PODD | ISRG / PODD | |
| Capitalization | 144B | 10.1B | 1,426% |
| EBITDA | 3.95B | 564M | 700% |
| Gain YTD | -28.176 | -48.719 | 58% |
| P/E Ratio | 49.43 | 34.06 | 145% |
| Revenue | 10.6B | 2.9B | 365% |
| Total Cash | 4.52B | 480M | 941% |
| Total Debt | 87M | 948M | 9% |
ISRG | PODD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 63 | 100 | |
SMR RATING 1..100 | 51 | 41 | |
PRICE GROWTH RATING 1..100 | 64 | 65 | |
P/E GROWTH RATING 1..100 | 84 | 87 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PODD's Valuation (72) in the Medical Specialties industry is in the same range as ISRG (79). This means that PODD’s stock grew similarly to ISRG’s over the last 12 months.
ISRG's Profit vs Risk Rating (63) in the Medical Specialties industry is somewhat better than the same rating for PODD (100). This means that ISRG’s stock grew somewhat faster than PODD’s over the last 12 months.
PODD's SMR Rating (41) in the Medical Specialties industry is in the same range as ISRG (51). This means that PODD’s stock grew similarly to ISRG’s over the last 12 months.
ISRG's Price Growth Rating (64) in the Medical Specialties industry is in the same range as PODD (65). This means that ISRG’s stock grew similarly to PODD’s over the last 12 months.
ISRG's P/E Growth Rating (84) in the Medical Specialties industry is in the same range as PODD (87). This means that ISRG’s stock grew similarly to PODD’s over the last 12 months.
| ISRG | PODD | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 57% | 4 days ago 59% |
| Stochastic ODDS (%) | 4 days ago 65% | 4 days ago 64% |
| Momentum ODDS (%) | 4 days ago 61% | 4 days ago 66% |
| MACD ODDS (%) | 4 days ago 50% | 4 days ago 63% |
| TrendWeek ODDS (%) | 4 days ago 63% | 4 days ago 76% |
| TrendMonth ODDS (%) | 4 days ago 69% | 4 days ago 79% |
| Advances ODDS (%) | 6 days ago 67% | 17 days ago 65% |
| Declines ODDS (%) | 20 days ago 59% | 6 days ago 72% |
| BollingerBands ODDS (%) | 4 days ago 79% | 4 days ago 64% |
| Aroon ODDS (%) | 4 days ago 65% | 4 days ago 77% |
Advertisement
ISRG and
Correlation & Price change
A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ISRG | 1D Price Change % | ||
|---|---|---|---|---|
| ISRG | 100% | +1.14% | ||
| BSX - ISRG | 73% Closely correlated | +0.76% | ||
| SYK - ISRG | 64% Loosely correlated | +2.21% | ||
| NTRA - ISRG | 54% Loosely correlated | +2.19% | ||
| GKOS - ISRG | 51% Loosely correlated | +2.57% | ||
| PODD - ISRG | 49% Loosely correlated | +1.56% | ||
More | ||||
PODD and
Correlation & Price change
A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To PODD | 1D Price Change % | ||
|---|---|---|---|---|
| PODD | 100% | +1.56% | ||
| ISRG - PODD | 49% Loosely correlated | +1.14% | ||
| SIBN - PODD | 39% Loosely correlated | +4.14% | ||
| ATEC - PODD | 39% Loosely correlated | +6.92% | ||
| MDT - PODD | 39% Loosely correlated | +1.54% | ||
| SYK - PODD | 39% Loosely correlated | +2.21% | ||
More | ||||